Your session is about to expire
← Back to Search
Electrophysiological Imaging for Ventricular Tachycardia (ECGI-VT Trial)
ECGI-VT Trial Summary
This trial is testing a new way to map and treat ventricular tachycardia, which contributes to over 350,000 sudden deaths each year in the US. The new method uses catheter ablation to "block" the channel that forms the circuit, with guidance from 3D images. The hope is that this will improve ablation efficacy and help clinicians identify ablation targets and assess ablation outcome.
ECGI-VT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowECGI-VT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ECGI-VT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have severe heart problems that limit your ability to do everyday activities.Your kidney function, measured by eGFR, is very low (less than 30).I am receiving medication through an IV to strengthen my heart muscle.I had a severe heart attack less than a month ago.My doctor expects I have less than 6 months to live or I am on the heart transplant list.I cannot or will not have a heart MRI or CT scan.I cannot undergo catheter ablation due to certain health issues.You have had a defibrillator implanted before.I am referred for a procedure to treat heart rhythm problems.I have had one or more episodes of a specific type of irregular heartbeat.
- Group 1: EP Imaging and Testing
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still opportunities to join this research endeavor?
"Clinicaltrials.gov reveals that this study is currently enrolling patients, having been published on November 1st 2019 and recently updated as of March 14th 2022."
Is eligibility for this trial restricted to individuals over the age of forty?
"This clinical trial is open to individuals aged 18 and older, up to 85 years of age."
What is the maximal capacity of participants permitted in this trial?
"Affirmative. As evidenced on clinicaltrials.gov, the trial that was initially published on November 1st 2019 is actively seeking participants; 20 patients must be sourced from one centre."
Would I be an eligible participant for this clinical experiment?
"Exclusively for those aged 18 to 85 who have suffered from myocardial infarction, this clinical trial is open to a maximum of 20 individuals."
Share this study with friends
Copy Link
Messenger